期刊文献+

sCD80-Linker-sCD40L融合基因重组腺病毒载体的构建及其在NIH3T3细胞的表达

Construction of recombinant adenoviral vector encoding sCD80-Linker-sCD40L fusion gene and its expression in NIH3T3 cells
下载PDF
导出
摘要 目的:构建人sCD80-Linker-sCD40L融合基因重组腺病毒载体,观测其在真核细胞中的表达。方法:以RT-PCR法从人外周血单个核细胞总RNA扩增IL12B亚基信号肽、sCD80和sCD40L编码序列,以重叠PCR法获得带有IL12B亚基信号肽的sCD80-Linker-sCD40L融合基因。使用AdMax腺病毒包装系统构建携带融合基因的重组腺病毒载体。以重组病毒感染NIH3T3细胞,观察融合基因的表达。结果:经测序证实,正确构建了携带sCD80-Linker-sCD40L融合基因的重组腺病毒载体。RT-PCR和Western blot证实融合基因在NIH3T3细胞中表达。结论:成功构建了携带sCD80-Linker-sCD40L融合基因的重组腺病毒载体,并在真核细胞中表达,为后续研究奠定了基础。 Objective: To construct a recombinant adenoviral vector containing sCD80-Linker-sCD40L fusion gene, and to evaluate the expression of the fusion protein in eukaryocyte. Methods: The coding gene of human IL12 B subunit signal peptide, sCD80 and sC D40L were cloned by RT-PCR from human peripheral blood mononuclear ceils. A sCD80-Linker-sCD40L fusion gene containing human IL12 B subunit signal peptide was constructed by overlap PCR, and AdMax Adenoviral Vector System was used to generate a recombinant adenoviral vector containing the sCD80-Linker-sCD40L fusion gene. NIH3T3 ceils were transfected with the recombinant adenovirus. The expression of the fusion gene in NIH3T3 ceils was observed. Results: The recombinant adenoviral vector containing sCD80-Linker-sCD40L fusion gene was constructed correctly, which was confirmed by DNA sequencing. The expression of the fusion gene in NIH3T3 ceils was detected with RT-PCR and Western blot. Concluslon: The successful construction of the recombinant adenoviral vector and the expression of sCD80-Linker-sCD40L fusion protein in eukaryocyte has laid a foundation for further researches.
出处 《天津医科大学学报》 2007年第3期332-335,共4页 Journal of Tianjin Medical University
基金 天津医科大学科研基金资助项目(2003KY33)
关键词 CD80 CD40L 融合基因 腺病毒载体 CD80 CD40L Fusion gene Adenoviral vector
  • 相关文献

参考文献8

  • 1Cignetti A,Vallario A,Follenzi A,et al.Lentiviral transduction of primary myeloma cells with CD80 and CD154 generates antimyeloma effector T cells[J].Human Gene Ther,2005,16(4):445.
  • 2Tong AW,Stone MJ.Prospects for CD40-directed experimental therapy of human cancer[J].Cancer Gene Ther,2003,10(1):1.
  • 3Kalady MF,Onaitis MW,Emani S,et al.Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity[J].J Surg Res,2004,116(1):24.
  • 4Chiriva-Internati M,Liu Y,Weidanz JA,et al.Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen,multiple myeloma HM1.24[J].Blood,2003,102(9):3100.
  • 5Frleta D,Lin JT,Quezada SA,et al.Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice[J].J Immunother,2003,26(1):72.
  • 6Haase C,Michelsen BK,Jorgensen TN.CD40 is necessary for activation of naive t cells by a dendritic cell line in vivo but not in vitro[J].Scand J Immunol,2004,59(3):237.
  • 7Cheadle EJ,Selby PJ,Jackson AM.Mycobacterium bovis bacillus Calmette-Guerin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism[J].Immunology,2003,108(1):79.
  • 8Zheng Y,Manzotti CN,Liu M,et al.CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells[J].J Immunol,2004,172(5):2778.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部